Merck Announces Formation of Merck Digital Ethics Advisory Panel
Designed to provide guidance around evolving digital business models, the panel will address digital ethics questions for all three business sectors of Merck. Merck, a […]
merck
Merck Acquires AmpTec to Expand mRNA Capabilities for Vaccines, Treatments and Diagnostics
Merck today announced the acquisition of AmpTec a leading Hamburg, Germany-based, mRNA contract development and manufacturing organization (CDMO). • Adds to Merck’s lipid manufacturing expertise, […]
Merck and Artios Pharma Announce a Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology
Merck and Artios today announced a global three year strategic research collaboration to discover and develop multiple precision oncology drugs. • Merck and Artios will […]
MERCK Changes in the leadership team of Performance Materials
Merck today announced another milestone of its transformation program “Bright Future” for the business sector Performance Materials. • Benjamin Hein will become General Manager and […]
Merck Collaborates with Mammoth Biosciences to Scale New SARS-CoV-2 Test
Merck today announced a collaboration with Mammoth Biosciences Inc. for the development, scale-up and commercial production of Mammoth’s CRISPR-based SARS CoV-2 diagnostic test. Merck, a […]
Merck Places Hybrid Bond Amounting to €1.0 billion
Merck, a leading science and technology company, today successfully placed a hybrid bond amounting to €1.0 billion. The placement has a maturity of 60 years […]
Merck today announced that it is launching a € 100,000 Community Involvement Initiative.
Performance Materials Launches € 100,000 Community Involvement Initiative Employees to engage in charitable projects in Asia, Africa and the United States A € 100,000 fund […]
Merck Announces Go-Live of Newly Integrated Performance Materials Organization
Merck today announced an important milestone in its Bright Future transformation program for its Performance Materials business. • After the acquisitions of Versum Materials and […]
MERCK Annual General Meeting Approves Dividend Proposal
Merck held its Annual General Meeting today. The company made use of the possibilities afforded by the German legislator in view of the coronavirus pandemic […]
Merck and Baylor College of Medicine Collaborate to Advance a Vaccine Manufacturing Platform to Fight Covid-19
Merck and Baylor College of Medicine, Houston, Texas, USA, today announced an extension of their ongoing collaboration to advance a manufacturing platform to fight Covid-19. […]
Merck: International Survey Reveals A Lack Of Knowledge About The Impact of Thyroid Disorders On Fertility
Results of the survey, initiated by Merck and conducted by YouGov, indicate a need to better educate people on the implications of undiagnosed thyroid disorders […]
New Late-Breaking Data at EAN Indicate Evobrutinib is the First BTK Inhibitor to Report Efficacy and Safety in MS Over 108 Weeks
• Investigational evobrutinib is the first and only Bruton’s Tyrosine Kinase inhibitor to demonstrate high and sustained efficacy through 108 weeks in clinical studies • […]